已发表论文

NUDT15  R139C 多态性与亚洲人对由硫嘌呤诱导的白细胞减少易感性的关系:荟萃分析

 

Authors Liu Y, Meng Y, Wang L, Liu Z, Li J, Dong W

Received 12 June 2018

Accepted for publication 8 October 2018

Published 23 November 2018 Volume 2018:11 Pages 8309—8317

DOI https://doi.org/10.2147/OTT.S177007

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr William Cho

Background and aim: Despite several studies being conducted to examine the associations between the NUDT15  R139C polymorphism and thiopurine-induced leukopenia in the Asian population, the results remain inconsistent. This meta-analysis determined the risk of thiopurine-induced leukopenia conferred by the NUDT15  R139C polymorphism.
Materials and methods: All eligible studies published in English up to May 2018 were identified by searching PubMed, Web of Science, Embase, and the Cochrane Library. Pooled OR and 95% CI were calculated using fixed- or random-effect model.
Results: In all, total of 14 studies containing 918 patients and 2,341 controls were included; of these, 8 studies concerned inflammatory bowel disease (IBD) and 4 concerned acute lymphoblastic leukemia (ALL). Overall, the results indicated that the NUDT15  R139C polymorphism was associated with leukopenia induced by thiopurines (OR =9.04, 95% CI 6.05–13.50, <0.001 for the dominant model; OR =24.26, 95% CI 11.38–51.71, <0.001 for the recessive model; OR =7.60, 95% CI 4.97–11.61, <0.001 for the CT vs TT model; OR =38.47, 95% CI 17.78–83.24, <0.001 for the CC vs TT model). In subgroup analyses, significant associations were found among patients with IBD (OR =7.57, 95% CI 5.16–11.12, <0.001 for the dominant model), ALL (OR =13.13, 95% CI 3.43–50.23 <0.001 for the dominant model), and other diseases (OR =31.22, 95% CI 1.20–814.07, =0.04 for the dominant model). In addition, the R139C variant was strongly associated with early (<8 weeks) (OR =15.53, 95% CI 7.91–30.50, <0.001 for the dominant model) and late leukopenia (≥8 weeks) (OR =2.92, 95% CI 2.01–4.24, <0.001 for the dominant model). Moreover, these findings were sufficiently robust when studies without Hardy–Weinberg equilibrium test were excluded.
Conclusion: This meta-analysis verified the strong association between the NUDT15  R139C polymorphism and thiopurine-induced leukopenia (both early and late leukopenia) in an Asian population with IBD, ALL, and other diseases. NUDT15  R139C genotyping should be prioritized to predict leukopenia among Asians.
Keywords: NUDT15  R139C, leukopenia, thiopurine, polymorphism, IBD, ALL, meta-analysis




Figure 1 Flow chart showing study selection procedure.